Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Global Market by Treatments, Causes, Drugs and Diet 2022-2027

 Market Highlights

It is estimated that the global IPF treatment market is expected to register a CAGR of 12.3% during the forecast period of 2022 to 2027, with a market value of USD 2,237 million in 2022.

IPF is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases. However, the high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment market.

The global idiopathic pulmonary fibrosis market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in September 2022, FibroGen, Inc. announced that the grant of Fast Track designation by US Food and Drug Administration (FDA) for the company’s anti-CTGF antibody, Pamrevlumab, for the treatment of patients with IPF.

Key Players

Some of the key players in the global IPF treatment market are Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La Roche AG, Fibrogen, Inc., Cipla, Merck & Co., Inc., Prometic Life Sciences Inc., and others.

Segmentation

The global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market has been segmented based on treatment.

The market, based on treatment, has been further divided into drug class, oxygen therapy, lung transplant, and others. The drug class segment is likely to hold a major share in the market due to the increasing adoption of the drugs for the treatment of IPF and wider preferability. The oxygen therapy segment is predicted to be the fastest growing due to the increasing inclination of medical professionals towards this therapy for the treatment of IPF.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The IPF treatment market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European IPF treatment market has been sub-divided Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, UK, Italy, Spain, and the rest of Western Europe. The IPF treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The IPF treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Intravascular Catheter Market by Forecast Revenue, Trends, Share, Demand by 2027

 Market Insights

Market Research Future (MRFR) estimated that the global intravascular catheter market is set to attain a market value of USD 4, 318 million, with a CAGR of 9.3% during the forecast period (2022-2027).

The global intravascular catheter market is driven by some of the various factors, such as the rising rate of hospitalization owing to the growing prevalence of infectious diseases. The increasing number of catheterization laboratories is anticipated to propel the growth of the market.

On the other hand, lack of expertise and advanced medical infrastructure in developing nations is expected to restrain the growth of the global intravascular catheter market. The increasing number of surgeries for the patients under treatment for chronic diseases, rise in demand for invasive surgical procedures by using catheters at ambulatory surgical centres are some of the critical drivers propelling the growth of the global intravascular catheters market.

Inadequate quality assurance, volatile pricing, and limited reimbursement in various developing nations are some the restraining factor in the global market. Increased count of surgeries for treating gastroenterology, cardiovascular, renal, and other diseases is one of the critical pointers driving the global intravascular catheter market.

Market Players

The global intravascular catheter market is driven by various leading players with their product offerings and services.  Some of these major players include Cook Medical, Medtronic Inc, Johnson & Johnson, C.R. Bard, Coloplast, Getinge AB, Terumo Corporation, Boston Scientific Corporation, Edwards Life Sciences Corporation, Terumo Corporation, McKesson Medical Surgical Inc, and Smiths Medical. Product developers are major adopting latest technologies such as connected devices and smart materials to build efficient and reliable products.

Market Segmentation

The global Intravascular Catheter Market is broadly bifurcated on the basis of product, application, and end-user.

Based on the product, the global market is diversified into integrated/closed PIVC catheters and short PIVC catheters.

The application segment is divided into cancer, renal disease, infectious diseases, gastrointestinal diseases, and other diseases.

The global end-user segment is split into hospitals, clinics, ambulatory surgical centers, home care, and others

Regional Insights

The global intravascular catheter market is dominated by the Americas, owing to a rise in per capita income, heavy adoption, and increased healthcare expenditure. Growing occurrences of hospital-acquired infection and the present of advanced healthcare facilities jointly foster the market growth in the North America region. Favorable reimbursement facilities related to intravascular catheters further motivate the market growth in the region.

The European intravascular catheter market is anticipated to grow exponentially while maintaining its dominance in the second position. The market is attributed to the existence of leading industry giants and the rising prevalence of deadly diseases.

Asia Pacific region is likely to grow rapidly owing to the massive patient population suffering from chronic diseases and government initiatives for healthcare reforms.

Moreover, the Rest of the World, specifically the Middle East & Africa, is anticipated to hold least share of the global intravascular catheter market. Low per capita incomes and volatile economic reforms are some of the factors restraining the growth of this regional market.

Recent Updates

The U.S. FDA called out two new guidance for labeling and testing of cardiac catheterization lab devices. Under the newly issued guidance, the wires, intravascular catheters, and delivery systems with lubricious coatings will be addressed with labeling considerations specially used for vasculature. The new guidance is believed to improve the reliability of coating-related information across these products portfolios with an assurance of safety on the use of these devices in the clinical setting.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Immunoprecipitation Market Diagnosis, Treatments and Global Key Players 2027

 Market Analysis

The global immunoprecipitation market is predicted to touch USD 562 million at a 5.2% CAGR over the forecast period (2022-2027), states the new Market Research Future (MRFR) report. Immunoprecipitation (IP), simply put, is a technique to precipitate a protein antigen out of a solution utilizing an antibody which specifically binds to that specific protein. The process can be used for isolating and concentrating a specific protein from a sample having thousands of various proteins. The IP technique help researchers in identifying the proteins activation status, determining protein modifications that are post-translational, measuring a given protein’s molecular weight, and capturing protein-binding molecules in both the study of protein-nucleic and protein-protein interactions.

Various factors are propelling the immunoprecipitation market growth. These factors, as per the new MRFR report, include increasing number of research activities in life science, growing need for identifying antigens related to autoimmune diseases, and increasing investments by industries and governments. Additional factors pushing market report include growing awareness regarding personalized therapeutics, rising biotechnology research, a growing number of immunoprecipitation assays to purify and isolate antigens, and repeat purchase of kits.

On the flip side, the availability of alternative protein purification technologies may hamper the immunoprecipitation market growth over the forecast period.

Key Players

Leading players profiled in the immunoprecipitation market report include Geno Technology Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals Inc., Takara Bio Inc., BioLegend, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, and Abcam plc, GenScript. Various strategies have been adopted by key players for capturing the competitive market such as partnerships, collaborations, mergers and acquisitions, research and development activities, and more.

April 2022: EpiCypher has signed an agreement with Thermo Fisher Scientific to offer co-exclusive usage of SNAP ChiP (sample normalization and antibody profiling for chromatin immunoprecipitation) technology that is specific for histone PTMS.

Market Segmentation

The MRFR report provides an all-inclusive segmental analysis of the Immunoprecipitation Market report on the basis of product, type, and end user.

Based on type, the immunoprecipitation market is segmented into RNA immunoprecipitation, chromatin immunoprecipitation, co-immunoprecipitation, and individual immunoprecipitation. Of these, the individual immunoprecipitation segment will have the largest share in the market over the forecast period. The individual immunoprecipitation is widely used to study protein-protein interactions for detecting the presence of antigens and determining its relative quantity that is driving its use in different research studies.

Based on product, the immunoprecipitation market is segmented into reagent, kit, and others. The reagent segment is again segmented into beads and antibodies. Antibodies are again segmented into primary as well as secondary. Beads are again segmented into buffers, magnetic beads, and agarose beads. Of these, the agarose beads segment will dominate the market over the forecast period.

Based on end user, the immunoprecipitation market is segmented into contract research organizations, academic and research institutes, pharmaceutical and biotechnology companies, and others. Of these, the pharmaceutical and biotechnology companies segment will lead the market over the forecast period chiefly due to the growing demand for protein-based drugs.

Regional Analysis

By region, the immunoprecipitation market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. Factors aiding growth in the region include the presence of several market players, increasing research activities, and a well-developed healthcare sector in the region.

The immunoprecipitation market in Europe is predicted to have the second-largest share in the market over the forecast period. This is chiefly due to the accessibility of funds for research.

The immunoprecipitation market in the APAC region is predicted to grow at the fastest pace over the forecast period. Factors aiding growth in the region include growing awareness regarding personalized therapeutics, growing biotechnology research in the region, and growing investment from governments.

The immunoprecipitation market in the Middle East and Africa is predicted to have a small share in the market over the forecast period.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Hemostasis and Tissue Sealing Agents Market Research by Key Types and Major Application, Analysis and Forecasts Till 2027

 Market Highlights

The global hemostasis and tissue sealing agents market is projected to grow at a CAGR of 8.6% over the forecast period. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation. Hemostasis and tissue sealing agents products are used in external surgical processes for reducing bleeding. For example, they are used in neurosurgical procedures, cardiac surgery, bariatric surgery, leg surgery, cesarean and orthopedic surgery. Hemostasis and tissue sealing agents products, are frequently used to reduce complexity and reduce recovery time after surgery. The high surgical procedure numbers lead to rising need for hemostasis and tissue sealing agents which reduces the risk during surgical procedures. However, factors such as increasing advancement minimally invasive procedures, lack of reimbursement for these products is hampering the growth of the market.

Key Players

Some of the prominent players in the global hemostasis and tissue sealing agents market are Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc and others.

Segmentation

The global hemostasis and tissue sealing agents market has been segmented into product, and end user.

By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant. Furthermore, topical hemostats is divided into Active, mechanical (collagen based hemostats, cellulose based hemostats, gelatin based hemostats, polysaccharide based hemostats) Flowable. Adhesive & tissue sealant is further segmented into synthetic, natural, and adhesion barrier.

Further on the basis of end user the market is bifurcated into hospitals, ambulatory centers and others

Regional Analysis

Geographically, the Americas is anticipated to dominate the global hemostatic agent market owing to the high clinical R&D budgets by both government as well as public and private organizations, presence of major manufacturers for the products, high number of surgical procedures and various others. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the U.S.

Europe is expected to hold the second largest position in the global hemostasis and tissue sealing agents market. The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others. The Middle East & Africa has the lowest share of the global hemostasis and tissue sealing agents market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Dental Lasers Market | Projected to Grow Radiantly by Top Players Revenue and Growth Rate by 2027

 Market Overview:

Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries. These lasers prevent the need for surgical instruments like coherent light beams, coherent light beams, and handpieces. Dental lasers also offer benefits like less contamination, less trauma, and less bleeding and are being accepted across the globe due to their ability like short healing time, lower light exposure, portability, and does not require anesthesia. The global dental lasers market, as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period (2017-2023).

The increasing number of dental disorders among the global population and surging awareness associated with oral hygiene is considered the key growth stimulants of the dental lasers market. Innovations made in treatment technologies and dental disorders diagnostics are estimated to offer the market a thrust. Advantages like reduced need for sutures and minimized bleeding are likely to encourage the market growth across the globe.

The rising spending on cosmetic dentistry is predicted to trigger the demand for dental laser equipment. Cosmetic dentistry is experiencing significant growth, especially in developed countries like Europe and North America owing to the high disposable income. As the aging population is prone to tooth decay and gum diseases, the surge in geriatric population suffering from dental lasers comparisons will further encourage the market growth in the foreseeable future.

On the contrary, dental lasers are expensive compared to their substitutes like dental drills, which is estimated to deter the market growth.

Competitive Dashboard:

The top players operating in the Dental Lasers Market include Biolase, Inc., AMD Lasers, Convergent Dental, Inc., Cao Group, Inc., Fotona D.D., Danaher Corporation- Kavo Dental GmbH, Millennium Dental Technologies, Inc., Ivoclar Vivadent AG, Syneron Dental Lasers-Syneron Medical Ltd., Sirona Dental Systems, Inc., Zolar Technology & MFG. Co. Inc., and The Yoshida Dental MFG. Co., Ltd.

Global Dental Lasers Market: Segmental Analysis

The dental lasers market has been segmented on the basis of application, product, and end users.

By product, the dental lasers market is segmented into all tissue dental lasers and soft tissue dental lasers. Of these, the soft tissue dental lasers segment will expand at a significant pace due to rising incidences of soft tissue disorders like gingivitis periodontal disorders.

The application segment comprises oral surgery, endodontic treatment, peri-implantitis, implantology, periodontics, and others. Of these, the periodontics segment will gain prominence due to the surging number of periodontics and increasing the spending power of the consumers.

The end users’ segment is segmented into ambulatory surgical units, hospitals & clinics, and academic & research organizations. Of these, the hospitals & clinics segment will gain prominence owing to the high availability of specialized physicians. Increased preferences for diagnosis and treatment at the clinics will further augment the market growth in the segment.

Regional Frontiers:

Geographically, the dental lasers market spans across Europe, Asia Pacific, North America, and the Middle East & Africa.

Considering the global scenario, North America is estimated to acquire the lion’s share and dominate the market, mainly due to the surging cases of dental diseases and increased expenditure on healthcare. As per a study by the National Institute of Dental & Craniofacial Research, around 92% of the adults are predicted to suffer from dental diseases. The existence of developed countries like Canada and the U.S. are further likely to influence the market growth in the region.

Europe bags the second spot with 30%-35% of the total market share. The growth of the regional market can be ascribed to the high dental healthcare expenditure, surging penetration of the market players, and increased government support for the dental sector.

The Asia Pacific is estimated to expand at a rapid pace due to the surging geriatric population, increased preferences for minimally invasive surgeries, and soaring awareness regarding dental lasers. The rapid boom in the dental industry has made the region lucrative for market expansion and development. The rising awareness regarding the guaranteed treatment of dental lasers has further encouraged the market growth. In this region, India is likely to experience significant growth due to surging number of dental diseases caused due to high consumption of alcohol, tobacco, and other products. Surging demand for cosmetic dentistry, coupled with the rising medical tourism will propel the market growth in the APAC.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

International Medical Gases and Equipment Market Professional Survey Forecasts by 2027

 Market Highlights:

The Global Medical Gases and Equipment Market held a market value of USD 13.0 billion in 2017 and is projected to grow at a CAGR of 7.5% over the forecast period. Medical gas is defined as the gas is manufactured, packaged, and used for administration to patients in diagnosis, anesthesia, and therapy. Medical gases are the life-saving element that provides direct influence in maintaining the life of patients. Medical gas equipment are the supply systems used by hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology industries to create or distribute medical gases in the piping system.

Few of the market growth factors are globally growing geriatric population coupled with increasing prevalence of chronic diseases, the presence of favourable government initiatives such as industry-friendly safety, and rising demand for point of care products & home healthcare. The Centers for Disease Control and Prevention (CDC) reported that, in the US, 6 in 10 adults have a chronic disease and 4 in 10 adults have two or more chronic diseases such as heart disease, cancer, chronic lung disease, stroke, diabetes, and chronic kidney disease (CKD)

Major Key Players

• Praxair Technology, Inc.
• Atlas Copco AB
• Air Liquide
• Airgas, Inc.
• Messer Group GmbH
• Matheson Tri-Gas, Inc.
• The Linde Group
• TAIYO NIPPON SANSO CORPORATION
• Amico Corporation
• SCI Analytical
• SOL S.p.A.
• Rotarex SA
• GCE Holding AB
• Air Products and Chemicals, Inc.
• Matheson Tri-Gas, Inc.
• Others

Segmentation:

The global Medical Gases And Equipment Market has been segmented into product, application, and end user.By product, the market has been segmented into medical gases, medical gas mixtures, and medical gas equipment. The medical gases segment has been further categorized into nitrogen gas, nitrous oxide gas, oxygen gas, carbon dioxide gas, helium gas, and medical air.

The medical gas mixtures segment is further categorized into medical laser gas mixtures, medical drug gas mixtures, sterilant gas mixtures, lung diffusion mixtures, blood gas mixtures, aerobic gas mixtures, anaerobic gas mixtures, and breathing zone monitoring calibration standard. The medical gas equipment is further categorized into air compressors, vacuum systems, flow meters, cylinders, alarm systems, masks, and others (manifolds, regulators, and outlets).

On the basis of application, the market has been segmented into therapeutic applications, diagnostic applications, pharmaceutical manufacturing & research, and others. The therapeutic applications segment is further categorized into respiratory therapies, cardiovascular therapies, anesthesia delivery, and others.Based on end user, the market has been segmented into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, and home healthcare.

Regional Analysis:

The Global medical gases and equipment market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is likely to dominate the global medical gases and equipment market owing to the increasing adoption of advanced technologies and the presence of major market players & target population in the U.S. and Canada. Europe will hold the second largest market position over the forecast period due to flourishing growth in medical device industry and the presence of medical gas associations, viz. the MGA (Medical Gas Association) and EIGA (European Industrial Gases Association)

The Asia-Pacific is anticipated to witness comparatively higher CAGR during the forecast period owing to growing population in India and China, increasing awareness among patients, caregivers and healthcare professionals about medical gases, and developing healthcare infrastructure in the region. The Middle East & Africa has the least share of the global medical gases and equipment market. Additionally, the major market share of the region would be held by the Middle East region attributed to rising incidences of conventional diseases and increasing technological innovations in the UAE, Saudi Arabia and Qatar.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Desalting and Buffer Exchange Market Therapeutics Review Analysis

 Market Highlights

The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. The increasing demand for monoclonal antibodies, increasing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to propel the growth of the market over the assessment period. On the other hand, the lack of skilled professionals is excepted to hinder the market growth during the forecast period.

The global desalting and buffer exchange column market is currently governed by a large number of market players. The prominent market players are engaged in strategic collaborations and mergers to strengthen its market presence. For instance, in August 2017, Thermo Fisher Scientific acquired Patheon, a contract development and manufacturing organization (CDMO).

Key Players

Some of the prominent players in the global desalting and buffer exchange market are Merck KGaA, GE Healthcare, Sartorius AG, Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Avantor, Repligen Corporation, Bio-works Technologies Ab, Norgen Biotek Corp, and Phynexus, Inc.

Segmentation

The Global Desalting and Buffer Exchange Market has been segmented into technique, product, and application. On the basis of technique, the global market has been segmented into filtration, chromatography, and precipitation. The filtration segment has been further segmented into ultrafiltration and dialysis. The chromatography segment has been segmented into size-exclusion chromatography and others.

The global desalting and buffer exchange market, by product, has been segmented into kits, cassettes, filter plates, spin columns, membrane filters, and others.

The market, on the basis of application, has been segmented into bioprocess applications and diagnostic applications. The bioprocess segment is expected to account for the largest market share in 2017. The market growth of the segment is attributed to the increasing demand for biopharmaceutical products.

Regional Analysis

Geographically, the Americas is expected to dominate the global market owing to the presence of well-developed healthcare sector, growing demand for biopharmaceuticals, continuously growing biotechnology sector, increasing research and development expenditures, and growing research activities in the field of genomics and proteomics research in the region. Europe is anticipated to hold the second position in the market owing to the growing number of research and development activities due to the growth in the R&D expenditure in the region. Asia-Pacific is anticipated to be the fastest growing region in the global market owing to the continuously growing biotechnology sector and growing number of geographical expansions of the prominent market players in the region. The Middle Eastern and African region is expected to hold the lowest market share owing to the limited developments in the healthcare sector, especially in the African region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America